Edan Yodfat, MD
Obstetrics & Gynecology · Ventura, CANPI 1750576880
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (55.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Intuitive Surgical at 39.0% of the total. Reporting peaked in 2019 at $3,589 and has fallen 56.9% since, to $1,548 in 2025. Among obstetrics & gynecology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 257 payments — averaging $52.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Axonics, Inc.$3K
- Coopersurgical, Inc.$1K
- Olympus Corporation Of The Americas$1K
- Exeltis, USA Inc.$709
- Astellas Pharma US Inc$668
- plus $2K from 18 others
What the payments were for
- Travel & lodging$7,36255%
- Food & beverage$6,00445%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 29 | $5,216 |
| Axonics, Inc. | 16 | $2,516 |
| Coopersurgical, Inc. | 49 | $1,209 |
| Olympus Corporation Of The Americas | 4 | $1,004 |
| Exeltis, USA Inc. | 40 | $709 |
| Astellas Pharma US Inc | 22 | $668 |
| Daiichi Sankyo Inc. | 28 | $504 |
| Sumitomo Pharma America, Inc. | 11 | $237 |
| Organon | 10 | $224 |
| Shield Therapeutics Inc | 11 | $199 |
| Biogen | 7 | $171 |
| AbbVie | 8 | $160 |
| Caldera Medical, Inc | 1 | $134 |
| Myovant Sciences Inc. | 6 | $109 |
| Evofem Biosciences, Inc. | 4 | $93 |
| Merck | 2 | $53 |
| Aspira Women's Health Inc | 1 | $42 |
| Pfizer | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| AMAG Pharmaceuticals, Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| Mylan Pharmaceuticals Inc. | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,858
- Axonics r-SNM System$1,171
- Bulkamid$1,171
- Axonics$990
- Olympus$969
- Veozah$140
- Desara$134
- Vertessa$134
- Twirla$128
- Slynd$128
How this compares
$13,387 in reported general payments places this provider in the 95th percentile of 3,784 obstetrics & gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Ventura
- Steve YuNorthridge$964K
- Samir HageRedlands$640K
- Malcolm MunroLos Angeles$609K
- Michael KrychmanCosta Mesa$547K
- Anita NelsonTorrance$530K
- Jan SegnitzSan Jose$511K
- Risa KaganBerkeley$497K
- Michael GreenOxnard$424K
- Howard SalvaySanta Cruz$421K
- Marc WinterLaguna Hills$399K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.